Local Activation of Interleukin 6 Signaling Is Associated With Arteriovenous Fistula Stenosis in Hemodialysis Patients

Hakim, 1998, Hemodialysis access failure: A call to action, Kidney Int, 54, 1029, 10.1046/j.1523-1755.1998.00122.x Weiss, 2001, Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access, Am J Kidney Dis, 37, 970, 10.1016/S0272-6386(05)80013-7 Kaysen, 2004, The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction, J Am Soc Nephrol, 15, 538, 10.1097/01.ASN.0000111744.00916.E6 Locatelli, 2001, Cardiovascular disease determinants in chronic renal failure: Clinical approach and treatment, Nephrol Dial Transplant, 16, 459, 10.1093/ndt/16.3.459 Cheung, 2000, The Hemodialysis (HEMO) Study, Int Soc Nephrol, 58, 353 Stenvinkel, 2002, Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: Association with Chlamydia pneumoniae seropositivity, Am J Kidney Dis, 39, 274, 10.1053/ajkd.2002.30546 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Kato, 2002, Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients, Kidney Int, 61, 1143, 10.1046/j.1523-1755.2002.00215.x Harris, 1999, Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly, Am J Med, 106, 506, 10.1016/S0002-9343(99)00066-2 Volpato, 2001, Cardiovascular disease, interleukin-6, and risk of mortality in older women, Circulation, 103, 947, 10.1161/01.CIR.103.7.947 Ridker, 2000, Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men, Circulation, 101, 1767, 10.1161/01.CIR.101.15.1767 Flex, 2002, The –174G/C polymorphism of the interleukin-6 gene promotor is associated with peripheral artery occlusive disease, Eur J Vasc Endovasc Surg, 24, 264, 10.1053/ejvs.2002.1711 Jenny, 2002, In the elderly, interleukin-6 plasma levels and the –174 G/C polymorphism are associated with the development of cardiovascular disease, Arterioscler Thromb Vasc Biol, 22, 2066, 10.1161/01.ATV.0000040224.49362.60 Hojo, 2002, Increased levels of monocyte-related cytokines in patients with unstable angina, Atherosclerosis, 161, 403, 10.1016/S0021-9150(01)00636-0 Heinrich, 1990, Interleukin-6 and the acute phase response, Biochem J, 265, 621, 10.1042/bj2650621 Yudkin, 2000, Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?, Atherosclerosis, 148, 209, 10.1016/S0021-9150(99)00463-3 Grotzinger, 1999, IL-6 type cytokine receptor complexes: Hexamer, tetramer or both?, Biol Chem, 380, 803, 10.1515/BC.1999.100 Heinrich, 1998, Interleukin-6-type cytokine signalling through the gp130/JAK/STAT pathway, Biochem J, 334, 297, 10.1042/bj3340297 Vermes, 2002, Shedding of interleukin-6 (IL-6) receptor (gp80) determines the ability of IL-6 to induce gp130 phosphorylation in human osteoblasts, J Biol Chem, 277, 16879, 10.1074/jbc.M200546200 Kurotani, 2001, Expression of interleukin-6, interleukin-6 receptor (gp80), and receptor’s signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas, Mod Pathol, 14, 791, 10.1038/modpathol.3880392 Podewski, 2003, Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy, Circulation, 107, 798, 10.1161/01.CIR.0000057545.82749.FF Dixon, 2002, Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula, Am J Kidney Dis, 39, 92, 10.1053/ajkd.2002.29886 Heine, 2003, Transforming growth factor beta1 genotype polymorphisms determine AV fistula patency in hemodialysis patients, Kidney Int, 64, 1101, 10.1046/j.1523-1755.2003.00176.x Fukasawa, 2003, The methylentetrahydrofolate reductase C677T point mutation is a risk factor for vascular access thrombosis in hemodialysis patients, Am J Kidney Dis, 41, 637, 10.1053/ajkd.2003.50125 Manns, 1999, Hyperhomocysteinemia, anticardiolipin antibody status, and risk for vascular access thrombosis in hemodialysis patients, Kidney Int, 55, 315, 10.1046/j.1523-1755.1999.00258.x De Marchi, 1996, Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients, J Am Soc Nephrol, 7, 1169, 10.1681/ASN.V781169 Papanicolaou, 1998, The pathophysiologic roles of interleukin-6 in human disease, Ann Intern Med, 128, 127, 10.7326/0003-4819-128-2-199801150-00009 Cavaillon, 1992, Serum interleukin-6 in long-term hemodialyzed patients, Nephron, 60, 307, 10.1159/000186770 Kaizu, 1998, Interleukin-6 may mediate malnutrition in chronic hemodialysis patients, Am J Kidney Dis, 31, 93, 10.1053/ajkd.1998.v31.pm9428458 Pertosa, 1993, Influence of hemodialysis on interleukin-6 production and gene expression by peripheral blood mononuclear cells, Kidney Int Suppl, 39, S149 Stenvinkel, 2001, The role of inflammation in the anaemia of end-stage renal disease, Nephrol Dial Transplant, 16, 36, 10.1093/ndt/16.suppl_7.36 Chang, 2005, Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity, Kidney Int, 68, 1312, 10.1111/j.1523-1755.2005.00529.x O’Brien, 1996, Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content, Circulation, 93, 672, 10.1161/01.CIR.93.4.672 Moulton, 2003, Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis, Proc Natl Acad Sci U S A, 100, 4736, 10.1073/pnas.0730843100